Scarica l'app Stockscreener
33.45
1.17%
0.505
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BAX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$32.94
Aprire:
$32.96
Volume 24 ore:
211.49K
Relative Volume:
0.05
Capitalizzazione di mercato:
$16.82B
Reddito:
$17.28B
Utile/perdita netta:
$108.00M
Rapporto P/E:
167.22
EPS:
0.2
Flusso di cassa netto:
$391.00M
1 W Prestazione:
-2.24%
1M Prestazione:
-5.49%
6M Prestazione:
-13.91%
1 anno Prestazione:
-19.78%
Intervallo 1D:
$32.80
$33.44
Intervallo di 1 settimana:
$32.80
$34.16
Portata 52W:
$28.34
$43.99
Baxter International Inc Stock (BAX) Company Profile
Nome
Baxter International Inc
Settore
Industria
Telefono
(847) 948-2000
Indirizzo
ONE BAXTER PKWY, DEERFIELD, IL
Confronta BAX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
33.42 | 16.82B | 17.28B | 108.00M | 391.00M | 0.20 |
|
ISRG
Intuitive Surgical Inc
|
514.07 | 182.21B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
229.30 | 66.11B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
91.44 | 45.01B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
223.97 | 32.73B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
225.01 | 16.82B | 2.88B | 499.60M | 321.60M | 6.74 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-26 | Ripresa | Goldman | Buy |
| 2025-02-24 | Aggiornamento | Argus | Hold → Buy |
| 2025-02-20 | Ripresa | Barclays | Overweight |
| 2024-07-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-10 | Downgrade | TD Cowen | Buy → Hold |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-01-06 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-12-19 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-12-15 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-12-12 | Downgrade | Citigroup | Buy → Neutral |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-06-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Downgrade | Goldman | Neutral → Sell |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-18 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | Reiterato | Morgan Stanley | Overweight |
| 2022-02-18 | Reiterato | Raymond James | Outperform |
| 2022-02-18 | Reiterato | Stifel | Buy |
| 2022-02-18 | Reiterato | UBS | Neutral |
| 2022-02-18 | Reiterato | Wells Fargo | Overweight |
| 2022-02-11 | Iniziato | Goldman | Neutral |
| 2022-01-07 | Ripresa | Citigroup | Buy |
| 2022-01-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2021-09-03 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2021-01-29 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | Downgrade | UBS | Buy → Neutral |
| 2020-12-15 | Downgrade | Goldman | Buy → Neutral |
| 2020-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-09-04 | Downgrade | Argus | Buy → Hold |
| 2020-06-24 | Iniziato | Oppenheimer | Outperform |
| 2020-03-19 | Aggiornamento | Stifel | Hold → Buy |
| 2020-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-02 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-12-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-01-02 | Aggiornamento | Citigroup | Neutral → Buy |
| 2019-01-02 | Aggiornamento | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | Aggiornamento | Argus | Hold → Buy |
| 2018-10-16 | Iniziato | Barclays | Underweight |
| 2018-05-17 | Ripresa | Piper Jaffray | Overweight |
| 2018-02-06 | Reiterato | Citigroup | Neutral |
| 2018-01-03 | Iniziato | Evercore ISI | Outperform |
| 2018-01-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
Mostra tutto
Baxter International Inc Borsa (BAX) Ultime notizie
Baxter Announces All-Digital Shareholder Meeting: How to Participate Virtually - StockTitan
Is Baxter International Stock Underperforming the S&P 500? - Nasdaq
Is Baxter International Stock Underperforming The S&P 500? - Barchart
KLP Kapitalforvaltning AS Acquires Shares of 174,176 Baxter International Inc. (NYSE:BAX) - MarketBeat
Hurricane Helene impact on Baxter to further limit IV fluid supply, HHS says - AOL
Sound Shore Management Inc. CT Purchases Shares of 2,484,581 Baxter International Inc. (NYSE:BAX) - MarketBeat
Parenteral Nutrition Research Analysis 2024: A Global $13.6 Billion Market by 2029, Driven by Increased Utilization of Premixed PN Formulations and Growing Preference for Home Parenteral Nutrition - GlobeNewswire Inc.
Short Interest in Baxter International Inc. (NYSE:BAX) Expands By 17.7% - MarketBeat
Baxter International: Navigating Leadership Transition and Market Growth Amidst Tariff Challenges - TipRanks
Tredje AP fonden Sells 39,465 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Update on Alert: Infusion Pump Issue from Baxter Healthcare Corporati - FDA.gov
Thompson Siegel & Walmsley LLC Boosts Stake in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter Wins Some Relief on Nevakar Blood-Pressure Drug Patents - Bloomberg Law
Here’s Why Baxter International (BAX) Fell in Q4 - Insider Monkey
Amundi Raises Holdings in Baxter International Inc. (NYSE:BAX) - MarketBeat
Carlyle Agrees to Buy Baxter’s Kidney Care Business for $3.8B - DocWire News
Baxter International Inc. (NYSE:BAX) Shares Sold by Cooke & Bieler LP - MarketBeat
Baxter International (BAX) Engages Stockholders with New Presentation - GuruFocus.com
Baxter International Appoints New Leadership Amid Strategic Changes - TipRanks
Baxter International (NYSE:BAX) Price Target Raised to $41.00 at Barclays - MarketBeat
E Fund Management Co. Ltd. Acquires Shares of 11,641 Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International’s SWOT analysis: medical supplies stock shows resilience - Investing.com
Baxter International’s SWOT analysis: medical supplies stock shows resilience By Investing.com - Investing.com South Africa
Baxter at Barclays Healthcare Conference: Strategic Focus on Growth - Investing.com
Baxter International Inc. (NYSE:BAX) Shares Sold by Cullen Frost Bankers Inc. - MarketBeat
Medical Specialty Bags Market Set to Witness Significant Growth by 2025-2032: Braun Melsungen AG, Baxter - EIN News
June 2026 Options Now Available For Baxter International (BAX) - Nasdaq
Baxter (BAX): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Baxter (BAX): Buy, Sell, Or Hold Post Q4 Earnings? - Barchart
DraftKings To Rally Over 29%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
Baxter International Inc Azioni (BAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.75%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):